Marinus Pharmaceuticals reported 14.19M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
ALKERMES ALKS:US $ 278.54M 45.92M
Amgen AMGN:US $ 6238M 608M
Aptinyx Inc APTX:US $ 0 0
Biogen BIIB:US $ 2531.8M 202M
Eisai 4523:JP Y 190901M 12071M
Enanta Pharmaceuticals ENTA:US $ 18.72M 8.93M
Esperion Therapeutics ESPR:US $ 18.84M 3.44M
Gilead Sciences GILD:US $ 6590M 654M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Marinus Pharmaceuticals MRNS:US 14.19M 12.67M
Neurocrine Biosciences NBIX:US $ 310.6M 1.4M
Ptc Therapeutics PTCT:US $ 148.74M 16.49M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
Supernus Pharmaceuticals SUPN:US $ 152.51M 6.54M
Vertex Pharmaceuticals VRTX:US $ 2097.5M 24.94M
YTE INCY:US $ 733.24M 129.62M